Greenwood Capital Associates LLC Has $499,000 Holdings in iCAD, Inc. (NASDAQ:ICAD)

Greenwood Capital Associates LLC trimmed its position in iCAD, Inc. (NASDAQ:ICAD) by 7.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 272,480 shares of the technology company’s stock after selling 22,667 shares during the period. Greenwood Capital Associates LLC’s holdings in iCAD were worth $499,000 at the end of the most recent quarter.

Separately, Essex LLC purchased a new stake in shares of iCAD in the 3rd quarter valued at approximately $216,000. Hedge funds and other institutional investors own 24.61% of the company’s stock.

iCAD Trading Up 7.8 %

Shares of iCAD stock opened at $3.30 on Wednesday. iCAD, Inc. has a 1 year low of $1.18 and a 1 year high of $3.78. The company has a market cap of $87.58 million, a P/E ratio of -25.38 and a beta of 1.47. The stock has a 50-day moving average price of $2.09 and a 200 day moving average price of $1.77.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of iCAD from a “hold” rating to a “sell” rating in a research note on Friday, January 31st.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.